Simplex Trading
CELU icon

Simplex Trading’s Celularity CELU Stock Holding History

Simplex Trading’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$73 Sell
55
-4,548
-99% -$5.76K ﹤0.01% 8889
2025
Q4 		$5.11K Sell
4,603
-4,848
-51% -$8.69K ﹤0.01% 7420
2025
Q3 		$19K Sell
9,451
-7,953
-46% -$22.3K ﹤0.01% 7356
2025
Q2 		$34K Buy
17,404
+6,498
+60% +$11.8K ﹤0.01% 6283
2025
Q1 		$18K Buy
10,906
+9,363
+607% +$17.7K ﹤0.01% 6642
2024
Q4 		$3K Sell
1,543
-1,925
-56% -$4.59K ﹤0.01% 7844
2024
Q3 		$10K Sell
3,468
-1,964
-36% -$5.79K ﹤0.01% 7173
2024
Q2 		$17K Buy
5,432
+3,675
+209% +$12.8K ﹤0.01% 7023
2024
Q1 		$9K Buy
+1,757
New +$7.22K ﹤0.01% 7657
2023
Q2 		– Sell
-98
Closed -$628 – 9045
2023
Q1 		$0 Sell
98
-222
-69% -$1.79K ﹤0.01% 9099
2022
Q4 		$4K Buy
+320
New +$5.9K ﹤0.01% 8177
2022
Q3 		– Sell
-3,806
Closed -$116K – 9967
2022
Q2 		$129K Buy
3,806
+3,801
+76,020% +$309K ﹤0.01% 5208
2022
Q1 		$0 Sell
5
-548
-99% -$32.8K ﹤0.01% 10464
2021
Q4 		$28K Buy
+553
New +$35.4K ﹤0.01% 7978
2021
Q2 		– Sell
-6,095
Closed -$618K – 10079
2021
Q1 		$614K Buy
+6,095
New +$625K ﹤0.01% 3067

Other funds holding CELU

CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return

Simplex Trading's CELU Position: Q1 2026 in Review

Simplex Trading reduced its Celularity (CELU) stake by 99% in Q1 2026, selling an estimated $5.76K and leaving 55 shares worth $73. The position accounts for ﹤0.01% of the portfolio, ranked #8889.

Simplex Trading first reported a position in CELU in Q1 2021 and has held it in 15 quarters since. The position peaked at $614K in Q1 2021. 38 funds tracked by Wall St. Rank hold CELU as of Q1 2026.

  • Simplex Trading held 55 shares of Celularity worth $73 as of Q1 2026.
  • Simplex Trading sold 4,548 Celularity shares in Q1 2026, an estimated $5.76K.
  • Celularity made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8889 holding.
  • Simplex Trading first reported a position in Celularity in Q1 2021 and has held it in 15 quarters since.
  • Simplex Trading's Celularity position peaked at $614K in Q1 2021.
  • 38 funds tracked by Wall St. Rank held Celularity as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.